Showing results (1051-1060 of 2,737) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|April 16, 2019
VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependenceMatthew Randesi, Wim van den Brink, Orna Levran, et al.
Pharmacogenomics|August 23, 2016
Minimum information required for a DMET experiment reportingJudit Kumuthini, Mamana Mbiyavanga, Emile R Chimusa, et al.
Pharmacogenomics|May 25, 2019
The impact of CYP2C19 and CYP4F2 variants and clinical factors on treatment outcomes during antiplatelet therapyVacis Tatarunas, Nora Kupstyte-Kristapone, Rita Norvilaite, et al.
Pharmacogenomics|May 25, 2019
Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y12 antagonistsBrittney H Davis, Chrisly Dillon, Anping Cai, et al.
Pharmacogenomics|March 28, 2018
Effect of hydrochlorothiazide on serum uric acid concentration: a genome-wide association studyEero M Ala-Mutka, Jenni M Rimpelä, Frej Fyhrquist, et al.
Pharmacogenomics|March 28, 2018
Pharmacogenetics of oral antidiabetic therapyAnna-Maria Ordelheide, Martin Hrabě de Angelis, Hans-Ulrich Häring, et al.
Pharmacogenomics|November 9, 2019
NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian populationRika Yuliwulandari, Kinasih Prayuni, Retno Wilujeng Susilowati, et al.
Pageof 274